These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10217347)

  • 21. Testing urine for drugs.
    Catlin D; Cowan D; Donike M; Fraisse D; Oftebro H; Rendic S
    Clin Chim Acta; 1992 May; 207(3):S13-26. PubMed ID: 1395022
    [No Abstract]   [Full Text] [Related]  

  • 22. Testing urine for drugs.
    Catlin DH; Cowan D; Donike M; Fraisse D; Oftebro H; Rendic S
    Ann Biol Clin (Paris); 1992; 50(5):359-66. PubMed ID: 1485694
    [No Abstract]   [Full Text] [Related]  

  • 23. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program.
    Klimas J; Muench J; Wiest K; Croff R; Rieckman T; McCarty D
    J Psychoactive Drugs; 2015; 47(1):65-70. PubMed ID: 25715074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine Multi-drug Screening with GC-MS or LC-MS-MS Using SALLE-hybrid PPT/SPE.
    Lee J; Park J; Go A; Moon H; Kim S; Jung S; Jeong W; Chung H
    J Anal Toxicol; 2018 Nov; 42(9):617-624. PubMed ID: 29762685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new automated assay for the detection of synthetic urine in drug testing.
    Silva F; Kaileh I; Hobbs GA
    Drug Test Anal; 2019 Jul; 11(7):926-930. PubMed ID: 30920168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
    Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
    J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment.
    Suzuki J; Zinser J; Issa M; Rodriguez C
    Subst Abus; 2017; 38(4):504-507. PubMed ID: 28723256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone dosing and pregnancy: impact on program compliance.
    DePetrillo PB; Rice JM
    Int J Addict; 1995 Jan; 30(2):207-17. PubMed ID: 7759173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does low urine creatinine level indicate the presence of urine alcohol in methadone maintenance treatment patients?
    Varenbut M; Plater-Zyberk CJ; Worster A; Daiter J
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):199-201. PubMed ID: 20536285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral fluid testing as an alternative to urine testing for drugs of abuse in inpatient forensic settings: giving patients choice.
    MacCall CA; Ritchie G; Sood M
    Scott Med J; 2013 May; 58(2):99-103. PubMed ID: 23728755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for the confirmation and identification of drugs of misuse in urine using solid phase extraction and gas-liquid chromatography with mass spectrometry.
    Galloway JH; Ashford M; Marsh ID; Holden M; Forrest AR
    J Clin Pathol; 1998 Apr; 51(4):326-9. PubMed ID: 9659249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of morphine and codeine in samples adulterated with Stealth.
    Cody JT; Valtier S; Kuhlman J
    J Anal Toxicol; 2001 Oct; 25(7):572-5. PubMed ID: 11599602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.
    Kreshak A; Villano J; Clark A; Deak P; Clark R; Miller C
    Am J Drug Alcohol Abuse; 2016 Mar; 42(2):178-86. PubMed ID: 26811262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of methadone and metabolite in patients under maintenance treatment.
    Diong SH; Mohd Yusoff NS; Sim MS; Raja Aziddin RE; Chik Z; Rajan P; Abdul Rashid R; Chemi N; Mohamed Z
    J Anal Toxicol; 2014; 38(9):660-6. PubMed ID: 25106416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.